Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1975 1
1976 1
1977 4
1978 1
1981 1
1982 1
1983 1
1985 5
1986 2
1987 2
1988 7
1989 10
1990 9
1991 12
1992 12
1993 13
1994 13
1995 19
1996 25
1997 17
1998 20
1999 16
2000 18
2001 12
2002 12
2003 28
2004 18
2005 36
2006 21
2007 16
2008 29
2009 37
2010 41
2011 44
2012 38
2013 59
2014 53
2015 52
2016 24
2017 28
2018 30
2019 24
2020 25
2021 21
2022 20
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

803 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial.
Ogata H, Fukagawa M, Hirakata H, Kagimura T, Fukushima M, Akizawa T; LANDMARK Investigators and Committees. Ogata H, et al. JAMA. 2021 May 18;325(19):1946-1954. doi: 10.1001/jama.2021.4807. JAMA. 2021. PMID: 34003226 Free PMC article. Clinical Trial.
OBJECTIVE: To determine whether lanthanum carbonate reduces cardiovascular events compared with calcium carbonate in patients with hyperphosphatemia at risk of vascular calcification undergoing hemodialysis. ...INTERVENTIONS: Patients were randomized to recei …
OBJECTIVE: To determine whether lanthanum carbonate reduces cardiovascular events compared with calcium carbonate in pa …
Calcium plus vitamin D supplementation and the risk of fractures.
Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SA, Black HR, Blanchette P, Bonds DE, Brunner RL, Brzyski RG, Caan B, Cauley JA, Chlebowski RT, Cummings SR, Granek I, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Johnson KC, Judd H, Kotchen JM, Kuller LH, Langer RD, Lasser NL, Limacher MC, Ludlam S, Manson JE, Margolis KL, McGowan J, Ockene JK, O'Sullivan MJ, Phillips L, Prentice RL, Sarto GE, Stefanick ML, Van Horn L, Wactawski-Wende J, Whitlock E, Anderson GL, Assaf AR, Barad D; Women's Health Initiative Investigators. Jackson RD, et al. N Engl J Med. 2006 Feb 16;354(7):669-83. doi: 10.1056/NEJMoa055218. N Engl J Med. 2006. PMID: 16481635 Free article. Clinical Trial.
We randomly assigned participants to receive 1000 mg of elemental [corrected] calcium as calcium carbonate with 400 IU of vitamin D3 daily or placebo. ...The risk of renal calculi increased with calcium plus vitamin D (hazard ratio, 1.17; 95 percent co …
We randomly assigned participants to receive 1000 mg of elemental [corrected] calcium as calcium carbonate with 400 IU …
Effect of lanthanum carbonate and calcium carbonate on the progression of coronary artery calcification among hemodialysis patients with vascular calcification risk: a randomized controlled trial.
Ogata H, Fukagawa M, Hirakata H, Kagimura T, Akizawa T; LANDMARK Investigators and Committees. Ogata H, et al. Clin Exp Nephrol. 2022 Dec;26(12):1223-1232. doi: 10.1007/s10157-022-02270-5. Epub 2022 Sep 5. Clin Exp Nephrol. 2022. PMID: 36064876 Clinical Trial.
BACKGROUND: Coronary artery calcification (CAC) is predictive of cardiovascular events. We assessed whether a non-calcium-based phosphate binder, lanthanum carbonate (LC), could delay CAC progression compared with a calcium-based phosphate binder, calcium …
BACKGROUND: Coronary artery calcification (CAC) is predictive of cardiovascular events. We assessed whether a non-calcium-based phosp …
Calcium Carbonate Attenuates Withdrawal and Reduces Craving: A Randomized Controlled Trial in Alcohol-Dependent Patients.
Schuster R, Winkler M, Koopmann A, Bach P, Hoffmann S, Reinhard I, Spanagel R, Bumb JM, Sommer WH, Kiefer F. Schuster R, et al. Eur Addict Res. 2021;27(5):332-340. doi: 10.1159/000512763. Epub 2021 Feb 10. Eur Addict Res. 2021. PMID: 33567423 Clinical Trial.
RESULTS: Based on an intention-to-treat protocol, withdrawal intensity (assessed with CIWA-Ar) in the calcium carbonate group attenuated faster than in the sodium bicarbonate subgroup. Alcohol craving (assessed with OCDS) in the calcium carbonate subgr …
RESULTS: Based on an intention-to-treat protocol, withdrawal intensity (assessed with CIWA-Ar) in the calcium carbonate group …
Calcium Citrate Versus Calcium Carbonate in the Management of Chronic Hypoparathyroidism: A Randomized, Double-Blind, Crossover Clinical Trial.
Naciu AM, Tabacco G, Bilezikian JP, Santonati A, Bosco D, Incognito GG, Gaspa G, Manfrini S, Falchetti A, Trimboli P, Mazziotti G, Napoli N, Sanson G, Cesareo R, Vescini F, Palermo A. Naciu AM, et al. J Bone Miner Res. 2022 Jul;37(7):1251-1259. doi: 10.1002/jbmr.4564. Epub 2022 Jun 24. J Bone Miner Res. 2022. PMID: 35466449 Free PMC article. Clinical Trial.
Our objective was to evaluate the potential therapeutic advantage of Ca-Cit in comparison with calcium carbonate (CaCO(3) ) in HypoPT, on nephrolithiasis risk factors, as well as to their ability to maintain desirable serum calcium levels. ...The primary outc …
Our objective was to evaluate the potential therapeutic advantage of Ca-Cit in comparison with calcium carbonate (CaCO(3) ) in …
Efficacy and safety of lanthanum carbonate versus calcium-based phosphate binders in patients with chronic kidney disease: a systematic review and meta-analysis.
Zhai CJ, Yang XW, Sun J, Wang R. Zhai CJ, et al. Int Urol Nephrol. 2015 Mar;47(3):527-35. doi: 10.1007/s11255-014-0876-x. Epub 2014 Nov 16. Int Urol Nephrol. 2015. PMID: 25399356 Review.
PURPOSE: We conducted this review to assess the relative efficacy and safety of lanthanum carbonate versus calcium-based phosphate binders in chronic kidney disease. ...Lanthanum carbonate was associated with significantly lower serum calcium, similar …
PURPOSE: We conducted this review to assess the relative efficacy and safety of lanthanum carbonate versus calcium-based phosp …
Calcium carbonate does not affect imatinib pharmacokinetics in healthy volunteers.
Tawbi H, Christner SM, Lin Y, Johnson M, Mowrey ET, Cherrin C, Chu E, Lee JJ, Puhalla S, Stoller R, Appleman LR, Miller BM, Beumer JH. Tawbi H, et al. Cancer Chemother Pharmacol. 2014 Jan;73(1):207-11. doi: 10.1007/s00280-013-2337-0. Epub 2013 Oct 30. Cancer Chemother Pharmacol. 2014. PMID: 24170263 Free PMC article. Clinical Trial.
Calcium carbonate could conceivably elevate gastric pH and complex imatinib, thereby influencing imatinib absorption and exposure. We aimed to evaluate whether use of calcium carbonate has a significant effect on imatinib pharmacokinetics. ...
Calcium carbonate could conceivably elevate gastric pH and complex imatinib, thereby influencing imatinib absorption and expos …
Calcium acetate or calcium carbonate for hyperphosphatemia of hemodialysis patients: a meta-analysis.
Wang Y, Xie G, Huang Y, Zhang H, Yang B, Mao Z. Wang Y, et al. PLoS One. 2015 Mar 23;10(3):e0121376. doi: 10.1371/journal.pone.0121376. eCollection 2015. PLoS One. 2015. PMID: 25799184 Free PMC article.
OBJECTIVES: To compare the efficacy and safety between calcium carbonate and calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients. ...CONCLUSIONS: For hyperphosphatemia treatment, calcium acetate showed better efficacy and wit …
OBJECTIVES: To compare the efficacy and safety between calcium carbonate and calcium acetate in the treatment of hyperp …
Relative bioavailability and pharmacokinetic comparison of calcium glucoheptonate with calcium carbonate.
Wiria M, Tran HM, Nguyen PHB, Valencia O, Dutta S, Pouteau E. Wiria M, et al. Pharmacol Res Perspect. 2020 Apr;8(2):e00589. doi: 10.1002/prp2.589. Pharmacol Res Perspect. 2020. PMID: 32302064 Free PMC article. Clinical Trial.
The objective of this study was to compare the relative oral bioavailability of calcium from calcium glucoheptonate, a highly soluble calcium salt containing 8.2% of elemental calcium, to that of calcium carbonate. ...The relative oral bi …
The objective of this study was to compare the relative oral bioavailability of calcium from calcium glucoheptonate, a highly …
Calcium carbonate does not affect nilotinib pharmacokinetics in healthy volunteers.
Tawbi HA, Tran AL, Christner SM, Lin Y, Johnson M, Mowrey E, Appleman LR, Stoller R, Miller BM, Egorin MJ, Beumer JH. Tawbi HA, et al. Cancer Chemother Pharmacol. 2013 Nov;72(5):1143-7. doi: 10.1007/s00280-013-2283-x. Epub 2013 Sep 14. Cancer Chemother Pharmacol. 2013. PMID: 24036846 Free PMC article. Clinical Trial.
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: Gastric upset is a common side effect of nilotinib therapy, and calcium carbonate is frequently used concomitantly, either as antacid or as calcium supplementation. ...CONCLUSIONS: Our results indicate that the use of …
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: Gastric upset is a common side effect of nilotinib therapy, and calcium carbonate is …
803 results

Searches related to "calcium carbonate"